Back
SELLAS Life Sciences Group, Inc. 10K Form
Buy
72
SLS
SELLAS Life Sciences Group, Inc.
Last Price:
$2.76
Seasonality Move:
1.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SLS News And Ratings
See the #1 stock for the next 7 days that we like better than SLS
SLS Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-7.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.36 |
| Price / Book: | 8.24 |
Profitability
| EPS (TTM): | -0.28690 |
|---|---|
| Net Income (TTM): | $-25.9M |
| Gross Margin: | $0 |
| Return on Equity: | -103.86% |
| Return on Assets: | -78.64% |
SELLAS Life Sciences Group, Inc. Earnings Forecast
Key SELLAS Life Sciences Group, Inc. Financial Ratios
-
Per Share Earnings over the last 19 years have been positive in 11 years.
SELLAS Life Sciences Group, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SLS |
| CUSIP: | 81642T |
| Website: | sellaslifesciences.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 8.28 |
| Quick Ratio: | 7.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SLS Technical Analysis vs Fundamental Analysis
Buy
72
SELLAS Life Sciences Group, Inc. (SLS)
is a Buy
Is SELLAS Life Sciences Group, Inc. a Buy or a Sell?
-
SELLAS Life Sciences Group, Inc. stock is rated a BuyThe current SELLAS Life Sciences Group, Inc. [SLS] share price is $2.64. The Score for SLS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.